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sive tubulointerstitial fibrosis in 5/6 nephrectomized rats.
Background. Tubulointerstitial fibrosis is the final common
pathway to end-stage renal failure. The present study investigated
the potential role of tubular epithelial cells (TEC) in progressive
fibrosis in the rat remnant kidney model.
Methods. Rats underwent 5/6 nephrectomy or a sham operation
(control), and groups of six animals were killed at weeks 1, 3, 5, 9,
13, 17 and 21.
Results. Immunohistochemistry staining and in situ hybridiza-
tion at week 3 after nephrectomy demonstrated de novo expres-
sion of alpha-smooth muscle actin (a-SMA)–a marker of smooth
muscle cells and myofibroblasts–by TEC that was invariably
associated with disruption of the tubular basement membrane
(TBM). This phenotypic evidence of tubular epithelial-myofibro-
blast transdifferentiation was supported by ultrastructural studies
identifying the presence of characteristic actin microfilaments and
dense bodies within TEC with a transformed morphology. In the
late stage of this apparent tubular epithelial-myofibroblast trans-
differentiation, TEC lost apical-basal polarity and tight junctions,
became elongated, detached from the TBM, separated from
neighboring cells and appeared to migrate into the peritubular
interstitium through the damaged basement membrane. Indeed,
focal peritubular accumulation of a-SMA1 myofibroblasts and
local tubulointerstitial fibrosis was closely associated with
a-SMA1 tubules, suggesting a tubular epithelial origin for some
of these cells. Quantitative analysis found a significant correlation
between the number of a-SMA1 TEC and the accumulation of
interstitial a-SMA1 myofibroblasts and the severity of tubuloin-
terstitial fibrosis (both P , 0.001).
Conclusions. This study provides phenotypic and morphological
evidence to support the hypothesis that TEC are pro-fibrogenitor
cells capable of tubular epithelial-myofibroblast transdifferentia-
tion in progressive renal fibrosis. In addition, we postulate that
disruption of the TBM, which facilitates epithelial cell contact
with the interstitial matrix, promotes this process of transdiffer-
entiation.
Tubulointerstitial fibrosis is the common final pathway
leading to end-stage renal failure. The severity of tubulo-
interstitial inflammation and fibrosis have long been con-
sidered as crucial determinants in progressive renal injury
and long-term prognosis in both human and experimental
glomerulonephritis [1–3], although the pathogenesis of
renal fibrosis remains poorly understood.
Tubulointerstitial fibrosis is characterized by the loss of
renal tubules and interstitial capillaries and the accumula-
tion of matrix proteins, such as collagen types I, III, IV, V,
VII, fibronectin and laminin [3]. Interstitial fibroblasts,
myofibroblasts, tubules and inflammatory cells have all
been identified as sources of the increased matrix protein
production in renal fibrosis [4–10]. Of these cell types,
much attention has recently been focused on the impor-
tance of myofibroblasts in progressive renal fibrosis. A
number of studies have shown that myofibroblasts–identi-
fied by their expression of a-smooth muscle actin (a-
SMA)–make a major contribution to the development of
glomerulosclerosis and interstitial fibrosis in both human
and experimental glomerulonephritis, with the number of
myofibroblasts providing an excellent prognostic indicator
of disease progression [4–14]. While the central role of
myofibroblasts in progressive renal fibrosis is becoming
widely accepted, the origin of these cells remains largely
unknown.
It has been postulated that tubular epithelial cells (TEC)
play an important role in tubulointerstitial fibrosis. TEC
can synthesize collagen both in vitro and in vivo [15–17].
Recent studies by Strutz and colleagues [18, 19] have
demonstrated that TEC are capable of de novo expression
of a fibroblast-specific protein (FSP1) in vitro and in vivo in
a mouse model of anti-tubular basement membrane (TBM)
nephritis. This has provided phenotypic evidence that TEC
have the ability to transdifferentiate into fibroblasts in
progressive tubulointerstitial fibrosis. However, further ev-
idence is required to support the hypothesis that transdif-
ferentiation of TEC contributes to renal fibrosis. First, can
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transdifferentiation of TEC give rise to a-SMA1 myofibro-
blasts, the major cell type causing renal fibrosis? Second,
morphological evidence of tubular epithelial-myofibroblast
transdifferentiation is needed to support the phenotypic
analysis.
In the current study, we have sought evidence of trans-
differentiation of TEC in the rat remnant kidney model.
Immunohistochemistry staining showed de novo expression
of a-SMA by TEC, mostly proximal tubules, while electron
microscopy showed the presence of characteristic actin
microfilaments and dense bodies within TEC with an
apparent transformed morphology.
METHODS
Experimental design
The study followed a previously published protocol [20].
A total of 84 male Sprague-Dawley rats (150 to 200 g) were
obtained from the Central Animal House, Yang Ming
University, Taiwan. Forty-two animals underwent subtotal
nephrectomy involving right subcapsular nephrectomy and
infarction of approximately two-thirds of the left kidney by
ligation of the posterior and one or two anterior extrarenal
branches of renal artery. After the surgery, rats were
randomly assigned into groups of six animals that were
sacrificed at weeks 1, 3, 5, 9, 13, 17 or 21. As a control, 42
rats underwent a sham operation consisting of laparotomy
and manipulation of the renal pedicles but without damage
to the kidney. Groups of six animals were sacrificed at the
same time points as described above.
Renal function and blood pressure
Blood samples and 24-hour urine collections were taken
prior to sacrifice on weeks 1, 3, 5, 9, 13, 17, and 21. Urinary
protein expression was determined using the Bio-Rad
Protein Assay (Bio-Rad laboratories, Hercules, CA, USA).
Serum and urine creatinine was measured with the stan-
dard Jaffe` rate reaction (alkaline picrate). All analyses
were performed by the Department of Clinical Biochemis-
try, Division of Nephrology, Veterans General Hospital,
Taipei. In addition, a weekly measurement of systolic blood
pressure was performed by rat tail plethysmograph (Narco
Bio-system, Houston, TX, USA).
Histology
Kidney tissues for histological examination were fixed in
10% formalin and 4 mm paraffin sections were stained with
hematoxylin and eosin or periodic acid-Schiff (PAS). The
Fig. 1. Analysis of renal function, blood pressure and tubulointerstitial
fibrosis after 5/6 nephrectomy in rats. (A) Twenty-four-hour urinary
protein excretion. (B) GFR measured by creatinine clearance. (C) Systolic
blood pressure. (D) Percent tubulointerstitial fibrosis. Each point repre-
sents the mean 6 SEM for groups of 6 rats given either 5/6 nephrectomy (F
and solid lines) or sham operated controls (E and dotted lines). *P , 0.05;
**P , 0.01; ***P , 0.001 versus sham operated controls.
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percentage of the cortical tubulointerstitium exhibiting
fibrosis was scored on PAS-stained sections by point-
counting technique on coded slides [21].
Antibodies
Monoclonal antibodies (mAb) used were: 1A4, anti-a-
SMA antibody that specifically recognized the smooth
muscle a-actin isoform (Sigma Chemical Co., St. Louis,
USA); PC10, mouse anti-proliferating cell nuclear antigen
(PCNA), which is expressed by proliferating cells in G1, S,
and G2 phases of the cell cycle (Dakopatts, Glostrup,
Denmark). In addition, peroxidase-conjugated goat anti-
mouse immunoglobulin, alkaline phosphatase-conjugated
goat anti-mouse immunoglobulin, mouse peroxidase anti-
peroxidase complexes (PAP) and mouse alkaline phospha-
tase anti-alkaline phosphatase complexes (APAAP) were
purchased from Dakopatts.
Immunohistochemistry
Double immunohistochemistry was performed using a
microwave-based two color staining technique [22]. Briefly,
sections were dewaxed, pre-incubated for 20 minutes in
10% FCS and 10% normal goat serum to block non-specific
binding, incubated with the anti-a-SMA mAb for 60 min-
utes and washed three times in phosphate buffered saline
(PBS). After inactivating endogenous peroxidase in 0.3%
H2O2 in methanol, sections were labeled sequentially with
peroxidase-conjugated goat anti-mouse IgG and PAP, fol-
lowed by development with diaminobenzidine to produce a
brown color. To block antibody cross-reactivity and facili-
tate antigen retrieval [22], sections were treated with two
rounds of microwave oven heating, each lasting five min-
utes, in 10 mM sodium citrate pH 6.0 at 2450 MHz and 800
watts power. After microwave treatment and pre-incuba-
tion as described above, sections were then incubated with
the PC-10 mAb for 60 minutes, followed by alkaline
phosphatase-conjugated goat anti-mouse IgG and APAAP.
Finally, sections were developed with Fast Blue BB Base
(Sigma Chemical Co.), counterstained with PAS without
hematoxylin, and coverslipped in an aqueous mounting
medium. Negative controls consisted of substitution of one
or both of the primary antibodies with equivalent concen-
tration of an irrelevant murine monoclonal antibody (73.5,
anti-human CD45R). All procedures were performed at
room temperature.
Quantitation of immunohistochemical staining
The total number of a-SMA1 myofibroblasts and the
number of a-SMA1PCNA1 proliferating and a-SMA1PCNA2
non-proliferating myofibroblasts within the tubulointersti-
tium were scored in double stained sections as previously
described [21]. Briefly, the number of nucleated a-SMA1,
PCNA1, a-SMA1PCNA1 and a-SMA1PCNA2 cells was
counted in at least 20 consecutive high power fields (340)
of the cortical interstitium using a 0.02 mm2 graticule fitted
in the eyepiece of microscope, moving from the outer to the
inner and back to the outer cortex. This procedure avoided
glomeruli and large vessels only. The percentage of
a-SMA1, PCNA1, a-SMA1PCNA1 and a-SMA1PCNA2
tubules was scored in at least 1000 consecutive cortical
tubular cross-sections as previously described [23]. Data
from groups of six animals are expressed as the mean 6 SEM
per square millimeter (mm2) of interstitium or percent
tubules. For all morphological analyses, the observer was
blinded to the animal group and the areas evaluated were
at a site distant from the surgical infarct area.
Probes
A 1,068 base pair cDNA fragment of rat vascular smooth
muscle a-actin [24] was amplified by the polymerase chain
reaction and cloned using the pMOSBlue T-vector kit
(Amersham International, Buckinghamshire, UK). Sense
and anti-sense digoxigenin (DIG)-labeled cRNA probes
were prepared using a T7 RNA polymerase kit (Boehringer
Mannheim GmbH, Mannheim, Germany). Probes were
precipitated and incorporation of DIG was determined by
dot blotting.
In situ hybridization
In situ hybridization was performed on 4 mm paraffin
sections of formalin-fixed tissue using a microwave-based
protocol [23, 25]. After dewaxing, sections were treated
with a microwave oven for 2 3 five minutes as described
above, incubated with 0.2 M HCl for 15 minutes, followed
by 1% Triton X-100 for 15 minutes, and then digested for
20 minutes with 10 mg/ml Proteinase-K at 37°C (Boehringer
Mannheim). Sections then were washed in 2 3 SSC,
prehybridized, and then hybridized with 0.3 ng/ml DIG-
labeled sense or anti-sense a-SMA cRNA probe overnight
at 37°C in a hybridization buffer containing 50% deionized
Fig. 2. In situ hybridization showing a-smooth muscle actin (a-SMA) mRNA expression by tubular epithelial cells in the rat remnant kidney. (a) Sham
operated animal showing strong a-SMA mRNA expression (dark brown) in vascular smooth muscle cells of an artery (A), but no signal is seen in tubules
or glomeruli. (b) Expression of a-SMA mRNA (dark brown) by some tubular epithelial cells with normal morphology in a week 3 nephrectomized rat,
representing the early stage of tubular epithelial-myofibroblast transdifferentiation. Note the disruption of the TBM (arrowheads) and the apparent
movement of one a-SMA1 tubular cell towards the interstitium (arrow). Serial sections (mirror image) showing strong expression of a-SMA mRNA
(dark brown) (c), and a-SMA protein (brown) (d), by TEC (arrows) within an area of early tubulointerstitial fibrosis at week 9 after nephrectomy. (e)
Combined detection of a-SMA mRNA (dark brown) and protein (blue) by tubular cells and interstitial myofibroblasts (arrows) in an area of
tubulointerstitial fibrosis. Note the TBM is thickened and wrinkled with partial and extensive disruption (arrowheads). (f) Late stage of tubulointerstitial
fibrosis showing strong a-SMA mRNA expression (dark brown) by spindle-like atrophic TEC in markedly dilated tubules (*) and interstitial
myofibroblasts. Note the TBM is partially and extensively damaged (arrowheads). All sections were counterstained with PAS. Magnification; 3100 (f),
3200 (a,c,d), 3400 (b,e). Publication in color was made possible by a grant from Merck Sharp & Dohme, Taipei, Taiwan.
4™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™
Ng et al: Transdifferentiation of tubular epithelium 867
formamide, 4 3 SSC, 2 3 Denhardt’s solution, 1 mg/ml
salmon sperm DNA, and 1 mg/ml yeast tRNA. Sections
were washed finally in 0.1 3 SSC at 37°C and the hybridized
probe detected using sheep anti-DIG antibody (Fab) con-
jugated with alkaline phosphatase and color development
with NBT/X-phosphate (Boehringer Mannheim). No signal
was seen with the sense riboprobe labeled to the same
specific activity.
As another specificity control, some sections were micro-
wave treated after in situ hybridization with the anti-sense
a-SMA cRNA probe and then stained with the anti-a-SMA
mAb using the three-layer APAAP method as described
above. All sections were counterstained with PAS minus
hematoxylin and mounted in an aqueous medium.
Electron microscopy
Kidney specimens for routine electron microscopy were
processed as previously described [26]. Briefly, small renal
tissue blocks obtained from renal cortex were fixed in 2.5%
glutaraldehyde in PBS (pH 7.4) for four hours, washed in
PBS, post-fixed with 1% osmium tetroxide, dehydrated in
graded alcohol, and embedded in Epon 812. Ultrathin
sections were stained with uranyl acetate and lead citrate
and examine in under a Zeiss electron microscope
(EM10C).
Statistical analysis
Renal function and histologic data were analyzed by one
way analysis of variance (ANOVA) from the Complete
Statistical Analysis program (CSS; Statsoft, Tulsa, IL,
USA). Correlation analysis between the different cell pop-
ulations scored in tissue sections and parameters of tubu-
lointerstitial fibrosis, renal function and blood pressure
were performed using the single Pearson coefficient.
RESULTS
Renal function and histology
Urinary protein excretion, creatinine clearance, blood
pressure, and renal histology remained within the normal
range throughout the entire experimental period in sham
operated control rats (Fig. 1). Following 5/6 nephrectomy,
however, rats developed severe proteinuria and chronic
renal failure with a significant fall in creatinine clearance
(Fig. 1 A, B). In addition, these animals had significantly
elevated systolic blood pressure (Fig. 1C). Morphologically,
there was marked tubular necrosis in the infarcted area at
week 1, while only small numbers of mononuclear cells
were seen within the non-infarcted tubulointerstitium. Sig-
nificant tubulointerstitial injury, including marked cellular-
ity and fibrosis, was evident at week 3 and increased
thereafter (Fig. 1D). Initially, tubulointerstitial fibrosis was
limited to the renal cortex and was local in nature, but
fibrosis became widespread throughout the cortex as dis-
ease progressed over weeks 9 to 21.
Interstitial myofibroblast accumulation and proliferation
Expression of a-SMA was used as a phenotypic marker
of myofibroblasts. No a-SMA mRNA or protein was de-
tected in glomeruli, cortical and medullary TEC or inter-
stitial cells in normal or sham-operated rats; however,
a-SMA mRNA and protein expression were readily ob-
served in vascular smooth muscle cells (Figs. 2a and 3a).
Few proliferating (PCNA1) cells were seen in the tubulo-
interstitial and glomerular compartments of normal and
sham operated rats (Fig. 3a). In contrast, rats undergoing
5/6 nephrectomy had a significant population of interstitial
a-SMA1 myofibroblasts at week 1, whose numbers peaked
at week 9 (Fig. 4a). Significant proliferation of interstitial
cells was evident over weeks 3 to 9, and double immuno-
staining demonstrated marked proliferation of interstitial
myofibroblasts (a-SMA1PCNA1 cells) during this time
(Fig. 4a). Indeed, local proliferation appears to have con-
tributed to myofibroblast accumulation in progressive in-
terstitial fibrosis.
Phenotypic evidence of tubular epithelial-myofibroblast
transdifferentiation
To seek phenotypic evidence of tubular epithelial-myo-
fibroblast transdifferentiation, we looked for de novo syn-
thesis of a-SMA by TEC. On week 3 following 5/6 nephrec-
tomy, de novo a-SMA mRNA and protein expression was
Fig. 3. Double immunohistochemistry showing tubular epithelial cell proliferation and myofibroblast transdifferentiation in the rat remnant kidney.
All sections are stained for a-SMA (brown) and PCNA (blue nuclei), with a PAS counterstain. (a) Week 21 sham-operated rat kidney showing normal
histology with occasional proliferating PCNA1 cells and a-SMA staining limited to vessels. (b) Week 3 nephrectomized rat showing individual and small
clusters of TEC express a-SMA within tubules with a normal structure, representing an early stage tubular epithelial-myofibroblast transdifferentiation.
Note that most a-SMA1 TEC are proliferating (PCNA1), and the presence of focal disruption of TBM adjacent to these a-SMA1 TEC as shown by
PAS-staining (arrowheads). (c) Week 3 nephrectomized rat showing apparent transformation of an entire tubule into a-SMA1 myofibroblasts with
complete disruption of the TBM and tubular structure. Most a-SMA1 cells are proliferating (PCNA1) and some have lost apical-basal polarity and
cell-cell adhesion (arrowheads), becoming elongated and separated from the neighbouring cells and appearing to migrate towards the peritubular
interstitium where numerous a-SMA1 myofibroblasts have accumulated. (d) Week 9 nephrectomized rat showing early development of focal
a-SMA-rich tubulointerstitial fibrosis in the immediate peritubular microenvironment of a-SMA1 tubules, representing an advanced stage of
tubular-myofibroblast transdifferentiation. (e) Week 17 nephrectomized rat showing extensive tubulointerstitial fibrosis in association with apparent
advanced tubular epithelial-myofibroblast transdifferentiation. Most a-SMA1 TEC have completely lost epithelial morphology, becoming spindle-like
with a markedly dilated tubular space. (f) Week 17 nephrectomized rat showing apparent tubular epithelial-myofibroblast transdifferentiation in
association with the development of severe tubulointerstitial fibrosis. Adjacent tubular cross-sections illustrate the early (*), advanced (**), and
completed stages of tubular epithelial-myofibroblast transdifferentiation (***) in association with tubulointerstitial fibrosis. Magnification: (a, e) 3250,
(b, d, f) 3320, (c) 3400. Publication in color was made possible by a grant from Merck Sharp & Dohme, Taipei, Taiwan.
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detected in some proximal TEC (Figs. 2b, 3b and 4B).
There was a progressive increase in the number of a-SMA1
tubules, peaking at week 9, and this paralleled the accumu-
lation of interstitial a-SMA1 myofibroblasts (Fig. 4). Tu-
bular expression of a-SMA was largely confined to proxi-
mal tubules and accounted for up to 5% of total cortical
tubules (Fig. 4B). Of note, double immunohistochemistry
showed that 60 to 80% of a-SMA1 TEC were proliferating
on the basis of PCNA expression (Figs. 3b-f and 4B). A
significant tubular proliferative response was evident at
week 1, which preceded the appearance of tubular a-SMA
expression at week 3 (Fig. 4B). This suggests that tubular
proliferation is an early response to renal ablation, while
the later appearance of a-SMA1 tubules may be driven by
the ongoing tubular injury. It should be pointed out that
most tubules (.85%) remained phenotypically normal and
did not proliferate during the disease course (Figs. 3b-f and
4B).
Based upon expression of a-SMA and morphology, we
observed two distinct stages of tubular epithelial-myofibro-
blast transdifferentiation in this model of progressive tubu-
lointerstitial fibrosis. In the early stage, individual tubules
contained single or multiple epithelial cells exhibiting de
novo a-SMA expression as shown in Figures 2b and 3b.
These a-SMA1 cells maintained a normal morphology and
apical-basal polarity. Notably, these a-SMA1 cells were
invariably associated with local disruption of the PAS-
stained TBM, even though the underlying TBM of the rest
of the tubule was intact. At this early stage, few peritubular
a-SMA1 myofibroblasts and no peritubular fibrosis were
seen around a-SMA1 TEC (Figs. 2b and 3b). Tubules in
the advanced stage of transdifferentiation showed strong
a-SMA mRNA and protein expression with extensive or
complete disruption of the TBM and numerous peritubular
a-SMA1 myofibroblasts (Fig. 2c-f and 3c-f). These tubules
lost their normal structure and cellular polarity. Indeed,
most a-SMA1 TEC become atrophic with a change of their
normal cubical morphology into spindle-shaped cells, lead-
ing to the development of an endothelial-like morphology
in markedly dilated tubules and severe tubulointerstitial
fibrosis (Fig. 2c-f and 3c-f). Of note, a-SMA1 TEC with
elongated morphology were seen detached and separated
from their neighbouring cells and appeared to migrate into
the peritubular area through the damaged tubular base-
ment membrane (Fig. 2b and 3c). This may explain the
origin of some, or even many, of the a-SMA1 interstitial
myofibroblasts seen in focal areas of tubulointerstitial
fibrosis (Fig. 3c-f). The different stages of tubular prolifer-
ation, tubular epithelial-myofibroblast transdifferentiation
and tubulointerstitial fibrosis are illustrated in Figure 3f.
In addition to the sense probe control, the specificity of
detection of a-SMA was confirmed by the use of in situ
hybridization and immunostaining for a-SMA mRNA and
protein, respectively, on serial sections and combined
within the same section (Fig. 2c-e).
Ultrastructural evidence of tubular epithelial-
myofibroblast transdifferentiation
The second aim of this study was to provide morpholog-
ical evidence of tubular epithelial-myofibroblast transdif-
ferentiation. Consistent with in situ hybridization and im-
munostaining results, no actin microfilaments were
observed in TEC in normal or sham operated rats by
transmission electron microscopy. However, ultrastructural
examination of rats after 5/6 nephrectomy demonstrated
the presence of characteristic cytoplasmic actin microfila-
ment bundles with many dense bodies (stress fibers) within
transformed TEC (Figs 5 to 7). Early and late stages of
tubular epithelial-myofibroblast transdifferentiation were
identified ultrastructurally. Early transformed TEC con-
tained a large-round or oval-shaped nucleus with abundant
auto-chromatin and numerous mitochondria, indicating
that these cells are “activated” with proliferative activity
(Fig. 5). This is consistent with immunohistochemistry
staining showing that most a-SMA1 TEC express PCNA.
Characteristic actin microfilaments with dense bodies were
seen in the basal side of transformed TEC lying parallel to
the partially-damaged TBM (Fig. 5). However, the early
transformed tubular cells maintained a normal structure
with features such as apical microvilli and tight junctions
intact (Fig. 5a). In the late, or advanced, stage of tubular
epithelial-myofibroblast transdifferentiation, cells exhibited
an elongated morphology with more abundant microfila-
ments and numerous dense bodies. In contrast to the basal
localization of actin microfilaments in the cytoplasm of
early transformed TEC, actin filaments in late stage trans-
formed cells were formed either in bundles parallel to the
main axis of the cell or in numerous single intermediate
fibers (6 nm diameter) that were distributed diffusely
throughout the entire cytoplasm (Figs. 6 and 7). The
apical-basal polarity, microvilli and tight junctions were
partially or completely lost from these cells, together with
the appearance of numerous vesicles within the cytoplasm
(Figs. 6 and 7a). In fibrotic areas, the TBM was extensively
damaged or disappeared entirely, being replaced with
collagen fibers (Fig. 7b). A well-developed endoplasmic
reticulum and numerous small vesicles, characteristic of
myofibroblasts, were found in these fibrotic areas (Fig. 7b).
Correlation of tubular a-smooth muscle actin expression
with tubulointerstitial fibrosis and progressive renal
injury
We examined the relationship between a-SMA1 TEC
and parameters of renal injury and fibrosis over the disease
course. As summarized in Table 1, there was a significant
correlation between the number of a-SMA1 TEC and
proteinuria, the loss of creatinine clearance and elevated
blood pressure. The number of interstitial myofibroblasts
and the degree of tubulointerstitial fibrosis also gave a
Ng et al: Transdifferentiation of tubular epithelium870
significant correlation with these parameters of renal in-
jury. In regard to the development of tubulointerstitial
fibrosis, there was a highly significant correlation between
tubular expression of a-SMA and the total number of
interstitial myofibroblasts, the number of proliferating in-
terstitial myofibroblasts and the degree of tubulointerstitial
fibrosis (Table 1).
DISCUSSION
This study has provided phenotypic and morphological
evidence to support the hypothesis that TEC transdifferen-
tiate into myofibroblasts during progressive tubulointersti-
tial fibrosis in the rat remnant kidney. These data suggest
that transdifferentiation of TEC may contribute to the
pathogenesis of tubulointerstitial fibrosis and progressive
renal injury.
Transdifferentiation of epithelium to mesenchyme and
of mesenchyme to epithelium occurs during embryonic
development. Apart from the collecting duct cells, all
kidney cells are derived from the metanephrogenic mesen-
chyme, a stem cell population that has the capacity to
differentiate either into epithelium or interstitium [27, 28].
Therefore, it is feasible that definitive TEC have the ability
to de-differentiate and transdifferentiate into a mesenchy-
mal phenotype under certain pathophysiological condi-
tions. Indeed, suspension of definitive epithelia from a
number of tissues, including tubular epithelial cell lines
(MDCK and NRK52E), in three-dimensional collagen type
I gels promotes epithelial-mesenchymal transdifferentia-
tion by turning off cytokeratin expression and turning on
mesenchymal gene programs [28–31]. Similarly, the culture
of primary distal (NP1) and transformed proximal (MCT)
tubular cell lines in three-dimensional collagen type I gels
induces expression of FSP1 and vimentin with the loss of
cytokeratin [18, 19]. These in vitro studies are supported by
the presence of occasional TEC showing de novo expres-
sion of FSP1 in a mouse model of anti-TBM disease [19].
The current study has used both in situ hybridization and
immunohistochemistry to show that TEC can express
a-SMA, providing evidence that TEC can transdifferenti-
ate into a-SMA1 myofibroblasts. A similar result was
recently reported in which some TEC exhibited immuno-
staining for a-SMA and lost expression of b-catenin during
the late stages of mouse models of Goodpasture’s syn-
drome and hereditary polycystic kidney disease [32]. In
addition to phenotypic changes, epithelial-mesenchymal
transdifferentiation involves morphological changes such as
a loss of cell-cell adhesion specialization and apical-basal
polarity, elongation, and becoming very invasive with a new
front end-back end mesenchymal polarity [28–31]. Similar
morphological changes were seen in a-SMA1 TEC in the
present study, including: (1) the loss of tight junctions and
apical-basal polarity; (2) development of an elongated
morphology, and (3) detachment from the TBM and
neighboring cells and the apparent migration into the
peritubular interstitium.
Myofibroblasts are morphologically intermediate be-
tween fibroblasts and smooth muscle cells. Therefore, like
fibroblasts, myofibroblasts have been shown to synthesis
collagen I and III [17, 33], while they retain a-SMA
expression. Like smooth muscle cells, myofibroblasts have
the ability to constrict, however, unlike smooth muscle
cells, they retain a high proliferative capacity as demon-
strated in experimental renal disease [7, 10]. Myofibroblasts
have recently been identified as a major fibrogenic cell type
and the best predictor of disease progression in both
experimental and human renal disease [6–10, 12–14, 34,
35]. Consistent with these findings, the present study of 5/6
nephrectomy in the rat demonstrated a significant correla-
tion between the number of tubular and interstitial
a-SMA1 cells with the degree of tubulointerstitial fibrosis
Fig. 4. Semiquantitation of a-SMA expression and proliferation by TEC
and interstitial cells during the development of tubulointerstitial fibrosis
in the rat remnant kidney. (A) Interstitium and (B) tubules were scored
for total a-SMA1 cells (E, dotted line), total PCNA1 proliferating cells
(f, solid line), and a-SMA1PCNA1 cells (F, dashed line). Each point
represents the mean 6 SEM for groups of 6 rats. *P , 0.05, **P , 0.01,
***P , 0.001 versus normal animals.
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Fig. 5. Ultrastructural evidence for the early stage of tubular epithelial-myofibroblast transdifferentiation. (a) A tubular epithelial cell contains
characteristic bundles of actin microfilaments with many dense bodies (arrowheads) on the basal side of the tubular epithelial peripheral cytoplasm, lying
parallel to partially disrupted (*) TBM. Note that the normal apical-basal polarity is maintained and the tight junction with the adjacent epithelial cell
is apparent (arrows). (b) A large bundle of actin microfilaments with many dense bodies (arrowheads) within the cytoplasm of a tubular epithelial cell.
Note the partial disruption of the TBM (*) (magnification, a 36,000 and b 312,000).
Fig. 6. Ultrastructural evidence for an intermediate stage of tubular epithelial-myofibroblast transdifferentiation. (a) Low power field showing a
transformed epithelial cell (*) within a tubule. The transformed cell has partially lost normal tubular epithelial structure with the appearance of large
bundles of actin microfilaments (open arrowheads) and numerous vesicles within the cytoplasm. In addition, there is a partial loss of microvilli on the
surface of the transformed cell (closed arrowheads) and tight junctions have disappeared. (b) High power of the same field showing actin microfilaments
with many dense bodies (arrowheads) parallel to the cell axis and detachment of the cell from the TBM (magnification, a 33,000 and b 312,000).
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Fig. 7. Ultrastructural evidence for the late stage of tubular epithelial-myofibroblast transdifferentiation. (a) A transformed tubular epithelial cell with
complete loss of surface microvilli (arrowheads), and abundant actin microfilaments and vesicles within the cytoplasm. (b) Characteristic myofibroblast
in the peritubular area with complete disruption of the TBM (*) (magnification, 312,000).
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and impairment of renal function, suggesting that myofi-
broblasts may play an active role in progressive renal injury.
The precise origin of the interstitial myofibroblasts re-
mains unknown. A number of studies have suggested that
interstitial myofibroblasts derive from the differentiation of
fibroblasts or migration from perivascular smooth muscle
cells [36–38]. In addition, results from this and other
studies have shown that local proliferation contributes, at
least in part, to the accumulation of myofibroblasts within
the interstitium and consequent tubulointerstitial fibrosis
[7, 10]. Furthermore, the results of the present study
suggest that tubular epithelial-myofibroblast transdifferen-
tiation and migration may also contribute to interstitial
myofibroblast accumulation in progressive tubulointersti-
tial fibrosis. This is supported by finding that a-SMA actin
expression is seen in TEC before becoming apparent in the
interstitium, the tight association between a-SMA1 TEC
and areas of myofibroblast-rich tubulointerstitial fibrosis,
and the highly significant correlation between the number
of a-SMA1 TEC and the number of a-SMA1 interstitial
myofibroblasts in the development of tubulointerstitial
fibrosis. Although unlikely on the basis of the phenotypic
and morphological data, we cannot formally exclude the
possibility that injured tubules with a-SMA expression are
invaded by interstitial a-SMA1 myofibroblasts giving rise
to tubules with the appearance of transdifferentiation.
Little is known of the mechanisms that may induce
tubular epithelial-myofibroblast transdifferentiation. The
invariant association between disruption of the TBM and
de novo a-SMA expression by TEC suggests that direct
interactions between the TEC and the extracellular matrix
environment of the interstitium is an important step in the
induction of the transdifferentiation process. This is sup-
ported by in vitro studies showing that laminin A, a
basement membrane component, plays a key role in initi-
ating polarity of tubular epithelial cells [39]. Indeed, acti-
vation of the mesenchymal gene program can be achieved
in definitive epithelia by simple modifications of the extra-
cellular matrix [28–31]. For example, growth of anterior
lens epithelium with intact basement membrane within
three-dimensional collagen gels gives rise to fibroblast-like
mesenchymal cells, whereas it maintains an epithelial mor-
phology when grown on top of collagen gels [28]. There-
fore, disruption of the TBM may be of fundamental
importance in the apparent transdifferentiation of TEC
into a-SMA1 myofibroblasts because it allows direct TEC
contact with the interstitial matrix, leading to activation of
the mesenchymal gene program and a loss of tubular
epithelial cell polarity, which facilitates the migration of
transformed TEC into the peritubular interstitium.
In summary, the present study has presented evidence to
support the hypothesis that TEC are pro-fibrogenitor cells
capable of transdifferentiation into myofibroblasts, which
participate in tubulointerstitial fibrogenesis. Epithelial-
myofibroblast transdifferentiation may be an important
inflammatory process in progressive tubulointerstitial fibro-
sis, leading to end-stage renal failure after subtotal ne-
phrectomy. Disruption of the TBM is a striking feature
associated with this transdifferentiation process, suggesting
that direct communication between TEC and the extracel-
lular matrix of the interstitium facilitates this fibrogenic
transdifferentiation. These findings provide a new insight
into the determinants of renal fibrogenesis and may open
up new avenues for therapeutic intervention in progressive
tubulointerstitial fibrosis leading to end-stage renal failure.
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APPENDIX
Abbreviations used in this article are: APAAP, alkaline phosphatase
anti-alkaline phosphatase; a-SMA, a-smooth muscle actin; DIG, digoxi-
genin; FCS, fetal calf serum; FSP1, fibroblast specific protein; mAB,
monoclonal antibody; PAP, peroxidase anti-peroxidase; PBS, phosphate
buffered saline; PCNA, anti-proliferating cell nuclear antigen; TBM,
tubular basement membrane; TEC, tubular epithelial cells.
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